Plc Glaxosmithkline
Director, Quest Diagnostics.
Companies
- Decibel Therapeutics, Inc.Board member Feb 11, 2021 to Feb 19, 20211
- Nkarta Therapeutics (United States)Board member Jul 9, 2020 to Jul 16, 20202
- Turning Point Therapeutics, Inc.Board member Apr 16, 2019 to May 26, 20203
- Orchard TherapeuticsBoard member Jan 2, 2020 to Jan 2, 20204
- Morphic Holding, Inc.Board member Jun 26, 2019 to Jul 2, 20195
- Bicycle Therapeutics (United Kingdom)Board member May 23, 2019 to May 30, 20196
- Quest DiagnosticsBoard member Mar 19, 2009 to Feb 2, 20117
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Recent filings
- Dec 11, 2025Bought 1,470,000 shares at $19.00 of Wave Life Sciences8
- Sep 27, 2024Bought 2,791,930 shares at $8.00 of Wave Life Sciences9
- Dec 7, 2023Bought 3,300,000 shares at $5.00 of Wave Life Sciences10
- Sep 16, 2022Other 9,644,807 shares at $9.75 of Theravance Biopharma, Inc.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGAROrchard Therapeutics, Board member
- 5SEC EDGARMorphic Holding, Inc., Board member
- 6
- 7SEC EDGARQuest Diagnostics, Board member
- 8SEC EDGARForm 4 filed Dec 15, 2025
- 9SEC EDGARForm 4 filed Oct 1, 2024
- 10SEC EDGARForm 4 filed Jan 30, 2024
- 11SEC EDGARForm 4 filed Sep 20, 2022